BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10789409)

  • 1. Routine coagulation screening in the management of emergency admission for epistaxis--is it necessary?
    Thaha MA; Nilssen EL; Holland S; Love G; White PS
    J Laryngol Otol; 2000 Jan; 114(1):38-40. PubMed ID: 10789409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of routine coagulation studies in idiopathic epistaxis.
    Pande NM; Jain SK; Mahore DM; Nitnaware AZ; Bokare BD; Sakhare PT
    Indian J Otolaryngol Head Neck Surg; 2006 Apr; 58(2):160-1. PubMed ID: 23120271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine clotting screen has no role in the management of epistaxis: reiterating the point.
    Shakeel M; Trinidade A; Iddamalgoda T; Supriya M; Ah-See KW
    Eur Arch Otorhinolaryngol; 2010 Oct; 267(10):1641-4. PubMed ID: 20379732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation studies in patients admitted with epistaxis--current practice in Scotland.
    Holland S; Thaha MA; Nilssen EL; White PS
    J Laryngol Otol; 1999 Dec; 113(12):1086-8. PubMed ID: 10767921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of coagulation profiles in epistaxis management.
    Jones GL; Browning S; Phillipps J
    Int J Clin Pract; 2003 Sep; 57(7):577-8. PubMed ID: 14529056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epistaxis: when are coagulation studies justified?
    Awan MS; Iqbal M; Imam SZ
    Emerg Med J; 2008 Mar; 25(3):156-7. PubMed ID: 18299365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995-2004.
    Walker TW; Macfarlane TV; McGarry GW
    Clin Otolaryngol; 2007 Oct; 32(5):361-5. PubMed ID: 17883556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the continuation of warfarin change management outcomes in epistaxis patients?
    Bola S; Marsh R; Braggins S; Potter C; Hickey S
    J Laryngol Otol; 2016 Mar; 130(3):256-60. PubMed ID: 26707504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: Routine coagulation testing in adult patients with epistaxis.
    Hodgson D; Burdett-Smith P
    Emerg Med J; 2011 Jul; 28(7):633-4. PubMed ID: 21700749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment algorithm for oral anticoagulant and antiplatelet therapy in epistaxis patients.
    Biggs TC; Baruah P; Mainwaring J; Harries PG; Salib RJ
    J Laryngol Otol; 2013 May; 127(5):483-8. PubMed ID: 23544790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omitting pre-operative coagulation screening tests in hip fracture patients: stopping the financial cascade?
    Salar O; Holley J; Baker B; Ollivere BJ; Moran CG
    Injury; 2014 Dec; 45(12):1938-41. PubMed ID: 25205647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Epistaxis-Effectiveness of Conservative Management.
    Hadar A; Peleg U; Ghantous J; Tarnovsky Y; Cohen A; Sichel JY; Attal P
    Pediatr Emerg Care; 2024 Jul; 40(7):551-554. PubMed ID: 38563814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epistaxis in Chiang Mai University Hospital.
    Chaiyasate S; Roongrotwattanasiri K; Fooanan S; Sumitsawan Y
    J Med Assoc Thai; 2005 Sep; 88(9):1282-6. PubMed ID: 16536117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between serum urea levels and outcome in acute epistaxis.
    Fishpool SJ; Foley K; Bul S; Whittet H
    B-ENT; 2015; 11(1):25-9. PubMed ID: 26513944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do all epistaxis patients with a nasal pack need admission? A retrospective study of 116 patients managed in accident and emergency according to a peer reviewed protocol.
    Van Wyk FC; Massey S; Worley G; Brady S
    J Laryngol Otol; 2007 Mar; 121(3):222-7. PubMed ID: 17040607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surgical audit in improving patient management; nasal haemorrhage: an audit study.
    Upile T; Jerjes W; Sipaul F; El Maaytah M; Nouraei SA; Singh S; Hopper C; Wright A
    BMC Surg; 2007 Sep; 7():19. PubMed ID: 17854499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiological profile and treatment outcomes of epistaxis at a major teaching hospital: a review of 721 cases.
    Carey B; Sheahan P
    Ir J Med Sci; 2018 Aug; 187(3):761-766. PubMed ID: 29197966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year all-cause mortality for 338 patients admitted with epistaxis in a large tertiary ENT centre.
    Corr MJ; Tikka T; Douglas CM; Marshall J
    J Laryngol Otol; 2019 Jun; 133(6):487-493. PubMed ID: 31062677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of FloSeal haemostatic agent in the management of epistaxis.
    Khan MK; Reda El Badawey M; Powell J; Idris M
    J Laryngol Otol; 2015 Apr; 129(4):353-7. PubMed ID: 25776997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial.
    Murray S; Mendez A; Hopkins A; El-Hakim H; Jeffery CC; Côté DWJ
    J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):3. PubMed ID: 29310703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.